ClinicalTrialsFinder

Non-small Cell Lung Cancer Recurrent Clinical Trials in St Louis, Missouri

1 recruitingSt Louis, Missouri

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer Stage IVNon-small Cell Lung Cancer Recurrent
Washington University School of Medicine26 enrolled1 locationNCT07355205